Thymosin Alpha 1 Acetate

Product Introduction

Thymosin alpha 1 is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function. It is an immune enhancing peptide that helps prevent infections such as the common cold or the flu and diseases, reduces inflammation in the body, aids in the removal of acute or chronic infections, has antibacterial, antiviral, and antifungal properties, supports the eradication of unhealthy cells, protects your cells against oxidative stress and damage, inhibits viral replication, and improves symptoms associated with chronic fatigue. Thymosin alpha 1 has been utilized in the treatment of immunocompromised states and malignancies, as an enhancer of vaccine response, and as a means of curbing morbidity and mortality in sepsis and numerous infections.

Thymosin-α1 (T-α1), a synthetic 28-amino acid peptide with multiple biological activities primarily directed towards immune response enhancement, is used for the treatment of HBV and hepatitis C virus (HCV) infections, and being developed for the treatment of non-small cell lung cancer (NSCLC), hepatocellular carcinoma, AIDS and malignant melanoma.